RICHARD SIPES: Open Payments
NPI 1528063252 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 21 payments from 7 companies in 2025. Trend: 2023 $219 · 2024 $334 · 2025 $747
Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $239 |
| Braeburn Inc. | 6 | $221 |
| Indivior Inc. | 5 | $95 |
| Janssen Pharmaceuticals, Inc | 2 | $71 |
| Alpha Cognition USA, Inc. | 2 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: BRIXADI, Epclusa, SUBLOCADE, INVEGA SUSTENNA, Zunveyl, AUSTEDO XR, Auvelity.
Industry payments across LA — which companies pay providers there.
